載入...

Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection

Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (pj) can lead to serious health consequences in patients with an immunocompromised system. Trimethoprim (TMP), used as first-line therapy in combination with sulfamethoxazole, is a selective but only moderately potent pj dihydrofolate red...

全面介紹

Na minha lista:
書目詳細資料
發表在:Bioorg Med Chem Lett
Main Authors: Khushbu, Shah, Sherry, Queener, Vivian, Cody, Jim, Pace, Aleem, Gangjee
格式: Artigo
語言:Inglês
出版: 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588427/
https://ncbi.nlm.nih.gov/pubmed/31176699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.06.004
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!